Education
About Us
Working with TipRanks
Follow Us
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
BALPHARMA Stock Chart & Stats
₹76.33
-₹1.73(-1.42%)
At close: 4:00 PM EST
₹76.33
-₹1.73(-1.42%)
Day’s Range― - ―
52-Week Range₹76.30 - ₹139.50
Previous CloseN/A
Volume11.87K
Average Volume (3M)4.08K
Market Cap
₹1.30B
Enterprise Value₹3.46B
Total Cash (Recent Filing)₹105.19M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)15.3
Beta0.59
Next Earnings
Feb 14, 2026EPS EstimateN/A
Last Dividend Ex-Date
Sep 18, 2025Dividend Yield1.58%
Share Statistics
EPS (TTM)0.45
Shares Outstanding15,920,872
10 Day Avg. Volume4,315
30 Day Avg. Volume4,084
Financial Highlights & Ratios
PEG Ratio-6.10
Price to Book (P/B)1.69
Price to Sales (P/S)0.43
P/FCF Ratio-9.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BALPHARMA FAQ
What was Bal Pharma Limited’s price range in the past 12 months?
Bal Pharma Limited lowest stock price was ₹76.30 and its highest was ₹139.50 in the past 12 months.
What is Bal Pharma Limited’s market cap?
Bal Pharma Limited’s market cap is ₹1.30B.
When is Bal Pharma Limited’s upcoming earnings report date?
Bal Pharma Limited’s upcoming earnings report date is Feb 14, 2026 which is in 75 days.
How were Bal Pharma Limited’s earnings last quarter?
Bal Pharma Limited released its earnings results on Nov 12, 2025. The company reported ₹0.446 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.446.
Is Bal Pharma Limited overvalued?
According to Wall Street analysts Bal Pharma Limited’s price is currently Overvalued.
Does Bal Pharma Limited pay dividends?
Bal Pharma Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 1.58%. See more information on Bal Pharma Limited dividends here
What is Bal Pharma Limited’s EPS estimate?
Bal Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bal Pharma Limited have?
Bal Pharma Limited has 15,920,872 shares outstanding.
What happened to Bal Pharma Limited’s price movement after its last earnings report?
Bal Pharma Limited reported an EPS of ₹0.446 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.832%.
Which hedge fund is a major shareholder of Bal Pharma Limited?
Currently, no hedge funds are holding shares in IN:BALPHARMA
Company Description
Bal Pharma Limited
Bal Pharma Limited (BALPHARMA) is a prominent pharmaceutical company based in India, specializing in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates in various therapeutic segments, including but not limited to, anti-infectives, cardiovascular, anti-diabetic, and neurological medications. With a strong focus on research and development, Bal Pharma aims to enhance healthcare outcomes through innovative and affordable pharmaceutical solutions.
Technical Analysis
Aarey Drugs & Pharmaceuticals Ltd.
―
Bafna Pharmaceuticals Limited
―
Krebs Biochemicals & Industries Ltd.
―
Mangalam Drugs & Organics Ltd.
―
Vaishali Pharma Ltd.
―